Brainstorm

Fortune Names Maryam Banikarim to Lead Its Most Powerful Women and Brainstorm Tech Franchises

Retrieved on: 
Thursday, March 7, 2024

NEW YORK, March 7, 2024 /PRNewswire/ -- Fortune Media announced today the appointment of Maryam Banikarim as Managing Director, Fortune Live Media.

Key Points: 
  • NEW YORK, March 7, 2024 /PRNewswire/ -- Fortune Media announced today the appointment of Maryam Banikarim as Managing Director, Fortune Live Media.
  • Banikarim will be responsible for the media company's prestigious Most Powerful Women (MPW) and Brainstorm Tech global franchises.
  • I couldn't be more excited to work with the talented group of journalists and professionals at Fortune to grow the Most Powerful Women and Brainstorm Tech franchises," said Banikarim.
  • Banikarim joins Fortune after being a guest co-chair of the 2023 Fortune Most Powerful Women summit and as a longtime member of the MPW community.

BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALS

Retrieved on: 
Friday, February 23, 2024

The submission follows an in-person meeting that BrainStorm held with the FDA in December 2023.

Key Points: 
  • The submission follows an in-person meeting that BrainStorm held with the FDA in December 2023.
  • The interactions leading up to this submission have provided guidance on advancing the planned Phase 3b trial.
  • Participating in an SPA program would allow BrainStorm to reach consensus with the FDA on its clinical trial design, including the proposed statistical analysis, before the study is initiated.
  • Stacy Lindborg, Ph.D., Co-CEO of BrainStorm added, "BrainStorm remains deeply committed to the ALS community.

Fortune Names Business Journalist Diane Brady to Dual Leadership Role for Fortune Live Media and Its Flagship CEO Initiative

Retrieved on: 
Wednesday, January 24, 2024

NEW YORK, Jan. 24, 2024 /PRNewswire/ -- Fortune Media announced today the appointment of Diane Brady, business journalist and author, as Executive Director of Fortune Live Media and Editorial Director of Fortune CEO Initiative, a key new leadership position in Fortune's expanding live media and executive community unit.

Key Points: 
  • Brady in key role to help drive Fortune's expanding global conferences, events and communities
    NEW YORK, Jan. 24, 2024 /PRNewswire/ -- Fortune Media announced today the appointment of Diane Brady, business journalist and author, as Executive Director of Fortune Live Media and Editorial Director of Fortune CEO Initiative, a key new leadership position in Fortune's expanding live media and executive community unit.
  • Starting Jan. 29th, Brady will be based at Fortune's headquarters in New York City, reporting to Anastasia Nyrkovskaya, Fortune's Chief Strategy Officer.
  • Brady will work closely with Fortune's global conference team, and with the editorial leadership reporting to Alyson Shontell, Editor-in-Chief of Fortune.
  • She will also curate Fortune's CEO Initiative, a global gathering of C-suite and executive leadership.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell Therapeutics Inc. - BCLI

Retrieved on: 
Tuesday, January 2, 2024

NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. (“Brainstorm” or the “Company”) (NASDAQ: BCLI).

Key Points: 
  • NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. (“Brainstorm” or the “Company”) (NASDAQ: BCLI).
  • The investigation concerns whether Brainstorm and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

DEADLINE ALERT for SEDG, BCLI, BCLYF/BCS, and OTLK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Tuesday, January 2, 2024

LOS ANGELES, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles

BCLI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Brainstorm Cell Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Tuesday, January 2, 2024

Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/ bcli .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/ bcli .
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • If you suffered a loss in Brainstorm Cell you have until January 2, 2024, to request that the Court appoint you as lead plaintiff.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

BCLI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Brainstorm Cell Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Wednesday, December 27, 2023

Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/ bcli .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/ bcli .
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • If you suffered a loss in Brainstorm Cell you have until January 2, 2024, to request that the Court appoint you as lead plaintiff.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

DEADLINE ALERT for SEDG, BCLI, BCLYF/BCS, and OTLK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Tuesday, December 26, 2023

LOS ANGELES, Dec. 26, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Dec. 26, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell Therapeutics Inc. - BCLI

Retrieved on: 
Friday, December 22, 2023

NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. (“Brainstorm” or the “Company”) (NASDAQ: BCLI).

Key Points: 
  • NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. (“Brainstorm” or the “Company”) (NASDAQ: BCLI).
  • The investigation concerns whether Brainstorm and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

BCLI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Brainstorm Cell Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Wednesday, December 20, 2023

Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/ bcli .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/ bcli .
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • If you suffered a loss in Brainstorm Cell you have until January 2, 2024, to request that the Court appoint you as lead plaintiff.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.